MANAV SALWAN: Open Payments
NPI 1457424301 · SYCAMORE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,801 in 90 payments from 20 companies in 2025. Trend: 2023 $1,262 · 2024 $1,638 · 2025 $1,801
Food & beverage: $1,801
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $239 |
| Amgen Inc. | 13 | $238 |
| Novo Nordisk Inc | 10 | $234 |
| GlaxoSmithKline, LLC. | 13 | $200 |
| Sumitomo Pharma America, Inc. | 8 | $146 |
| Lilly USA, LLC | 5 | $128 |
| PFIZER INC. | 5 | $106 |
| Teva Pharmaceuticals USA, Inc. | 4 | $82 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $81 |
| ABBVIE INC. | 3 | $65 |
Products named: TRELEGY ELLIPTA, GEMTESA, Wegovy, JARDIANCE, Ozempic, MOUNJARO, AUSTEDO XR, OTEZLA.
Industry payments across IL — which companies pay providers there.
